|
1
|
Sontheimer H: Brain cancer: Tumour cells
on neighbourhood watch. Nature. 528:49–50. 2015.PubMed/NCBI
|
|
2
|
Geng F, Cheng X, Wu X, Yoo JY, Cheng C,
Guo JY, Mo X, Ru P, Hurwitz B, Kim SH, et al: Inhibition of SOAT1
suppresses glioblastoma growth via blocking SREBP-1-mediated
lipogenesis. Clin Cancer Res. 22:5337–5348. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Brada M, van den Bent MJ, Tonn JC
and Pentheroudakis G; ESMO Guidelines Working Group: High-grade
glioma: ESMO clinical practice guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 25:iii93–iii101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu Y, Zhao S, Cui M and Wang Q:
Down-regulation of microRNA-135b inhibited growth of cervical
cancer cells by targeting FOXO1. Int J Clin Exp Pathol.
8:10294–10304. 2015.PubMed/NCBI
|
|
5
|
Yamagata K, Daitoku H, Takahashi Y, Namiki
K, Hisatake K, Kako K, Mukai H, Kasuya Y and Fukamizu A: Arginine
methylation of FOXO transcription factors inhibits their
phosphorylation by Akt. Mol Cell. 32:221–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coomans de Brachène A and Demoulin JB:
FOXO transcription factors in cancer development and therapy. Cell
Mol Life Sci. 73:1159–1172. 2016. View Article : Google Scholar
|
|
7
|
Song HM, Song JL, Li DF, Hua KY, Zhao BK
and Fang L: Inhibition of FOXO1 by small interfering RNA enhances
proliferation and inhibits apoptosis of papillary thyroid carcinoma
cells via Akt/FOXO1/Bim pathway. Onco Targets Ther. 8:3565–3573.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li CF, Zhang WG, Liu M, Qiu LW, Chen XF,
Lv L and Mei ZC: Aquaporin 9 inhibits hepatocellular carcinoma
through up-regulating FOXO1 expression. Oncotarget. 7:44161–44170.
2016.PubMed/NCBI
|
|
9
|
Cheng C, Jiao JT, Qian Y, Guo XY, Huang J,
Dai MC, Zhang L, Ding XP, Zong D and Shao JF: Curcumin induces G2/M
arrest and triggers apoptosis via FoxO1 signaling in U87 human
glioma cells. Mol Med Rep. 13:3763–3770. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen H, Wang D, Li L, Yang S, Chen X, Zhou
S, Zhong S, Zhao J and Tang J: MiR-222 promotes drug-resistance of
breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1
pathway. Gene. 596:110–118. 2017. View Article : Google Scholar
|
|
11
|
Arrigoni E, Galimberti S, Petrini M,
Danesi R and Di Paolo A: ATP-binding cassette transmembrane
transporters and their epigenetic control in cancer: An overview.
Expert Opin Drug Metab Toxicol. 12:1419–1432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen QY, Wu LJ, Wu YQ, Lu GH, Jiang ZY,
Zhan JW, Jie Y and Zhou JY: Molecular mechanism of trifluoperazine
induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol
Med Rep. 2:811–817. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shin SY, Choi BH, Kim JR, Kim JH and Lee
YH: Suppression of P-glycoprotein expression by antipsychotics
trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells.
Eur J Pharm Sci. 28:300–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Polischouk AG, Holgersson A, Zong D,
Stenerlöw B, Karlsson HL, Möller L, Viktorsson K and Lewensohn R:
The antipsychotic drug trifluoperazine inhibits DNA repair and
sensitizes non small cell lung carcinoma cells to DNA double-strand
break induced cell death. Mol Cancer Ther. 6:2303–2309. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeh CT, Wu AT, Chang PM, Chen KY, Yang CN,
Yang SC, Ho CC, Chen CC, Kuo YL, Lee PY, et al: Trifluoperazine, an
antipsychotic agent, inhibits cancer stem cell growth and overcomes
drug resistance of lung cancer. Am J Respir Crit Care Med.
186:1180–1188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Xu ZY and Wang F: Association
between DNA methylation and multidrug resistance in human glioma
SHG-44 cells. Mol Med Rep. 11:43–52. 2015. View Article : Google Scholar
|
|
17
|
Wen K, Fu Z, Wu X, Feng J, Chen W and Qian
J: Oct-4 is required for an antiapoptotic behavior of
chemoresistant colorectal cancer cells enriched for cancer stem
cells: effects associated with STAT3/Survivin. Cancer Lett.
333:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang N, Cheng S, Mi X, Tian Q, Huang Q,
Wang F, Xu Z, Xie Z, Chen J and Cheng Y: Downregulation of nitrogen
permease regulator like-2 activates PDK1-AKT1 and contributes to
the malignant growth of glioma cells. Mol Carcinog. 55:1613–1626.
2016. View
Article : Google Scholar
|
|
19
|
Chen S, Zhao H, Deng J, Liao P, Xu Z and
Cheng Y: Comparative proteomics of glioma stem cells and
differentiated tumor cells identifies S100A9 as a potential
therapeutic target. J Cell Biochem. 114:2795–2808. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sangodkar J, Dhawan NS, Melville H, Singh
VJ, Yuan E, Rana H, Izadmehr S, Farrington C, Mazhar S, Katz S, et
al: Targeting the FOXO1/KLF6 axis regulates EGFR signaling and
treatment response. J Clin Invest. 122:2637–2651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Z, Qin L and Li S: miR-411
contributes the cell proliferation of lung cancer by targeting
FOXO1. Tumour Biol. 37:5551–5560. 2016. View Article : Google Scholar
|
|
22
|
Ding H, Zhu Y, Chu T and Wang S: Epidermal
growth factor induces FoxO1 nuclear exclusion to activate
MMP7-mediated metastasis of larynx carcinoma. Tumour Biol.
35:9987–9992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pei J, Lou Y, Zhong R and Han B: MMP9
activation triggered by epidermal growth factor induced FoxO1
nuclear exclusion in non-small cell lung cancer. Tumour Bio.
35:6673–6678. 2014. View Article : Google Scholar
|
|
24
|
Myatt SS, Wang J, Monteiro LJ, Christian
M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S and Lam EW:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar
|
|
25
|
Hou T, Ou J, Zhao X, Huang X, Huang Y and
Zhang Y: MicroRNA-196a promotes cervical cancer proliferation
through the regulation of FOXO1 and p27Kip1. Br J Cancer.
110:1260–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Magro G, Righi A, Casorzo L, Antonietta T,
Salvatorelli L, Kacerovská D, Kazakov D and Michal M: Mammary and
vaginal myofibroblastomas are genetically related lesions:
Fluorescence in situ hybridization analysis shows deletion of 13q14
region. Hum Pathol. 43:1187–1193. 2012. View Article : Google Scholar
|
|
27
|
Zhang X, Tang N, Hadden TJ and Rishi AK:
Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta.
1813.1978–1986. 2011.
|
|
28
|
Lian R, Lu B, Jiao L, Li S, Wang H, Miao W
and Yu W: MiR-132 plays an oncogenic role in laryngeal squamous
cell carcinoma by targeting FOXO1 and activating the PI3K/AKT
pathway. Eur J Pharmacol. 792:1–6. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Altan B, Yokobori T, Ide M, Mochiki E,
Toyomasu Y, Kogure N, Kimura A, Hara K, Bai T, Bao P, et al:
Nuclear PRMT1 expression is associated with poor prognosis and
chemosensitivity in gastric cancer patients. Gastric Cancer.
19:789–797. 2016. View Article : Google Scholar
|
|
30
|
Van Der Heide LP, Hoekman MF and Smidt MP:
The ins and outs of FoxO shuttling: Mechanisms of FoxO
translocation and transcriptional regulation. Biochem J.
380:297–309. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zou J, Hong L, Luo C, Li Z, Zhu Y, Huang
T, Zhang Y, Yuan H, Hu Y, Wen T, et al: Metformin inhibits
estrogen-dependent endometrial cancer cell growth by activating the
AMPK-FOXO1 signal pathway. Cancer Sci. 107:1806–1817. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun F, Han DF, Cao BQ, Wang B, Dong N and
Jiang DH: Caffeine-induced nuclear translocation of FoxO1 triggers
Bim-mediated apoptosis in human glioblastoma cells. Tumour Biol.
37:3417–3423. 2016. View Article : Google Scholar
|
|
33
|
Yuan K, Yong S, Xu F, Zhou T, McDonald JM
and Chen Y: Calmodulin antagonists promote TRA-8 therapy of
resistant pancreatic cancer. Oncotarget. 6:25308–25319. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pulkoski-Gross A, Li J, Zheng C, Li Y,
Ouyang N, Rigas B, Zucker S and Cao J: Repurposing the
antipsychotic trifluoperazine as an antimetastasis agent. Mol
Pharmacol. 87:501–512. 2015. View Article : Google Scholar : PubMed/NCBI
|
